
BioRad.io Podcast Series
The BioRad.io podcast series is focused on R&D informatics, introducing you to people responsible for implementing systems and technologies to a diverse set of use-cases. Join us every month to see what you can learn.

Hanging with My Chromies Podcast Series
The Hanging with My Chromies podcast series is focused on the many surprising applications of chromatography and the stories surrounding them. Join us every month to see what you can learn.

Episode 1: Moving to the Cloud
Listen to the podcast. PROLOGUE Charlene Son Rigby: They are really looking to get their test validated and launch their test as quickly as possible. Being able to do that …

Brilliant Science Podcast Series
The Brilliant Science podcasts will introduce you to some of the amazing science being done around the world. Join us every month to see what you can learn.

Say Hello to Your Littlest Friends — the Microbiota
How well do you understand your microbiota? Dr. Allyson Byrd of Genentech, the fourth guest on Brilliant Science, is a bioinformatician focusing on parsing all the data our microbiomes have to offer. Read about the value of analyzing microbiota and how Dr. Byrd hopes to leverage the results.

Finding New Horizons — What Possibilities Exist with Single-Cell Analysis?
Single-cell techniques offer exciting, new ways to understand personalized medicine and research. Developing these techniques at Bio-Rad is Dr. Kelly Kaihara, the third guest on Brilliant Science. Read about what makes single-cell analysis different and Kaihara’s perspective on its potential moving forward.

Phagocytosis and Phasing Out Disease
Our immune systems could soon hold the key to rewriting disease and disorder treatments. Studying the inner workings of the immune system’s primary weapon, the macrophage, with the help of CRISPR is Dr. Adam Hoppe at SDSU. Read more about his exciting work and what he hopes to accomplish next.

NYU Prof Harnesses CRISPR to End Muscular Dystrophy
On the scientific horizon are possibilities of curing genetic disorders and altering disease management — all because of CRISPR. Investigating exciting approaches to reversing the effects of muscular dystrophy with the help of CRISPR is Dr. Chengzu Long at NYU. Read more about his life, his work, and where he sees CRISPR going next.

The Ups and Downs of Biosimilar Development
In this podcast, biosimilar key opinion leader Dr. Paul Rhyne provides an overview of the current state of biosimilars and their global impact. Leveraging his 20+ years of experience in developing biologics, he discusses how cost and patient access play a big role in this new field of research.

Top Five Podcasts of 2017
2017 saw the launch of Bioradiations’ first-ever podcast! Here you can listen to the top five podcasts we published this year, and learn about a variety of topics from CRISPR gene editing to what biomarkers and biosimilars are.